Bacillus coagulans
Bacillus coagulans is a spore-forming bacterium studied as a probiotic candidate, in part because its spores exhibit heat and acid stability, a property studied in relation to survival through food processing and gastric transit. The available strain-specific evidence for this entry is heterogeneous and includes food safety studies, fermentation research, and industrial applications alongside limited probiotic data. A 2020 randomized controlled trial examined a preparation containing B. coagulans alongside another organism (C. butyricum) in the context of Helicobacter pylori eradication, though the multi-organism design limits attribution to this species alone. Genome-based safety assessments exist for certain B. coagulans strains, but efficacy data for this specific unnamed strain are limited. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 748 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 261 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+17 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
1959 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 42196985 →Efficacy and Safety of Bacillus coagulans IDCC 1201 for Sleep Improvement in Adults with Sleep Disturbance: A Randomized, Double-Blind, Placebo-Controlled Polysomnographic Study· Nutrients · 2026
-
[2]
Source →Heyndrickxia coagulans as a Next-Generation ProbioticHeyndrickxia Coagulans как пробиотик нового поколения· Ernst Journal of Animal Science · 2026
-
[3]
PMID 41915321 →Genomic analysis, tolerance, and probiotic potential of Bacillus coagulans mr-1B isolated from the hindgut of Macrobrachium rosenbergii against Vibrio parahaemolyticus· International Microbiology · 2026
-
[4]
PMID 41641154 →Oral health benefits of Heyndrickxia coagulans: a systematic review and meta-analysis of current evidence· Frontiers in Oral Health · 2026
-
[5]
Source →Therapeutic Potential of Bacillus Coagulans Unique IS2 Probiotic Supplementation on Early Periodontitis Patients: A Randomized Controlled Trial· International Arab Journal of Dentistry · 2026
-
[6]
Source →Supplementation of horses with B. coagulans GBI-30,6086 protects against gastrointestinal inflammation· Journal of Equine Veterinary Science · 2025
-
[7]
PMID 41262831 →Testing the Immunomodulatory Effects of Probiotic Bacillus coagulans SNZ 1969® in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial· Cureus · 2025
-
[8]
PMID 40456531 →Bacillus coagulans Unique IS2 improves stool characteristics in healthy adults with infrequent bowel movements: a randomized, double-blind, placebo-controlled trial· Beneficial Microbes · 2025
-
[9]
Source →A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Heat-Inactivated Heyndrickxia Coagulans Mtcc 5856 (Immunospore®) in Healthy Human Participants· SSRN Electronic Journal · 2025
-
[10]
PMID 40416368 →Effect of Bacillus coagulans BC99 supplementation on body weight and gut microbiota in overweight and obese individual: a randomized, double-blind, placebo-controlled study· Frontiers in Nutrition · 2025